Altmetrics
Downloads
39
Views
17
Comments
0
A peer-reviewed article of this preprint also exists.
Submitted:
04 December 2024
Posted:
05 December 2024
You are already at the latest version
Amount in human organism (g) | Blood serum level | Daily allowance | Young´s modulus (GPa) | In vitro corrosion rate (mm/year) | |
---|---|---|---|---|---|
Fe | 5 | 5 - 17.6 g/L | 10 - 20 mg | 200 | 0.012 |
Mg | 25 | 1.6 - 2.5 mg/dL | 0.7 g | 41 - 45 | 0.10 ± 0.07 |
Zn | 2 | 60 - 120 µg/dl | 12 - 15 mg | 96 | 0.08 |
Properties | Unit | Value | ||
---|---|---|---|---|
Zn | Fe | Mg | ||
Density (20 ˚C) | g/cm3 | 7.14 | 7.874 | 1.74 |
Melting point | ˚C | 419.5 | 1538 | 650 |
Boiling point | ˚C | 907 | 2862 | 1091 |
Heat conductivity (20 ˚C) | W/m·K | 113 | 80 | 158 |
Heat conductivity (melting point) | W/m·K | 61 | 40 | 78 |
Specific heat (20 ˚C) | J/kg K | 382 | 444 | 1360 |
Surface tension (melting point) | mN/m | 782 | 1835 | 559 |
Viscosity (melting point) | mPa·s | 3.85 | 6.93 | 1.25 |
Laser absorptivity (powder, 20 ˚C) | % | 70 | 75 | / |
Human bone | 40-79 | ||
Material | SLM | Cast | Wrought |
Pure Fe | 150 ± 6.5 | 130 (Mild steel) | 150 (Mild steel) |
Fe35Mn | 163 ± 4.0 | n/a | n/a |
AISI 316L | 245 ± 6.0 | 175 | 220 |
Pure Zn | 45 ± 5.4 | n/a | 34 ± 2 |
Pure Mg | 78 ± 8.2 | 30 ± 2 | ± 2 |
Material | Energy density (J/mm3) | E (GPa) | σ0.2(MPa) | UTS(MPa) | Compressive strength at 20% strain [MPa] |
Ref |
---|---|---|---|---|---|---|
Human Cortical Bone | - | 1–35 | 1–20 | 103–140 | [53] | |
Cast Fe | - | 202.5 ± 6.70 | 157.1 ± 7.7 | 497.8 ± 7.5 | [52] | |
Cast Fe35Mn | - | 240 | 440 | [53] | ||
SLM pure Fe | 185 | 205.67 ± 16 | 245.87 ± 17 | 354.27 ± 18 | - | [51] |
SLM pure Fe | 152 | 208.77 ± 16 | 256.57 ± 17 | 356.67 ± 22 | - | |
SLM pure Fe | 143 | 210.57 ± 18 | 285.47 ± 20 | 402.77 ± 24 | - | |
SLM pure Fe | 125 | 215.87 ± 20 | 305.37 ± 22 | 411.57 ± 25 | - | |
SLM pure Fe | 67 | 199.70 ± 6.70 | 421.1 ± 16 | - | 760.2 ± 6.5 | [52] |
Material | Part | Energy density (J/mm3) | Corrosion test | Conditions | CR (mm/year) | icorr (mA/cm2) | Rp (Ω cm2) |
Ref. |
---|---|---|---|---|---|---|---|---|
Cast Fe | - | - | Electrochemical test | OCP: measured for 150 minutes EIS: amplitude of 10mV with scanning frequency between 100 kHz and 10 mHz. Lp: ±0.25 V (vs. SCE) at a scan rate of 0.166mVs-1. |
0.047 ± 0.003 | 4.05 ± 0.3 | 1410 | [52] |
Col rolled iron | Electrochemical test | OCP: measured for 60 minutes EIS: amplitude of 10mV with scanning frequency between 100 kHz and 10 mHz Lp: -0.3 - +0.5 V (vs. SCE) at a scan rate of 0.5mVs-1 |
0.10 ± 0.01 | 0.0086 ± 0.0009 | - | [63] | ||
Col rolled iron | Immersion test | Samples immersed for 28 days in r-SBF | - | [63] | ||||
SLM Pure Fe | Dense | 67 | Electrochemical test | OCP: measured for 150 minutes EIS: amplitude of 10mV with scanning frequency between 100 kHz and 10 mHz. Lp: ±0.25 V (vs. SCE) at a scan rate of 0.166mVs-1. |
0.072 ± 0.001 | 6.2 ± 0.1 | 1035 | [52] |
SLM Pure Fe | Scaffold | 10 | Electrochemical test | EIS: amplitude of 10mV with scanning frequency between 100 kHz and 10 mHz | - | 0.00738 ± 0.00321 | [55] | |
SLM Pure Fe | Scaffold | 10 | Immersion test | Samples immersed for 30 days in SBF with a pH of 7.4 | 0.09 ± 0.02 | [55] | ||
SLM Pure Fe | Scaffold | - | Electrochemical test | OCP: measured for 60 minutes EIS: amplitude of 10mV with scanning frequency between 100 kHz and 10 mHz Lp: -0.3 - +0.5 V (vs. SCE) at a scan rate of 0.5mVs-1 |
1.18 ± 0.22 | 0.1028 ± 0.0192 | - | [63] |
SLM Pure Fe | Scaffold | - | Immersion test | Samples immersed for 28 days in r-SBF | 0.03 | - | [63] | |
SLM Pure Fe | Scaffold S0.2 | - | Immersion test | Samples immersed for 28 days in r-SBF | 0.19446 | - | - | [60] |
SLM Pure Fe | Scaffold (Dense-in) | - | Immersion test | Samples immersed for 28 days in r-SBF | 0.1389 | - | - | [60] |
SLM Pure Fe | Scaffold (Dense-out) | - | Immersion test | Samples immersed for 28 days in r-SBF | 0.17131 | - | - | [60] |
SLM Pure Fe | Scaffold S0.4 | - | Immersion test | Samples immersed for 28 days in r-SBF | 0.12501 | - | - | [60] |
SLM Pure Fe | Scaffold | Electrochemical test | OCP: measured for 60 minutes Lp: -0.2 - +0.5V (vs. SCE) at a scan rate of 0.1mVs-1 |
0.049 | 0.0042 | [64] | ||
SLM Fe25Mn | Scaffold | 10 | Electrochemical test | EIS: amplitude of 10mV with scanning frequency between 100 kHz and 10 mHz | - | 0.05125 ± 0.00752 | [55] | |
SLM Fe25Mn | Scaffold | 10 | Immersion test | Samples immersed for 30 days in SBF with a pH of 7.4 | 0.23 ± 0.05 | [55] | ||
SLM Fe30Mn | Scaffold | Electrochemical test | OCP: measured for 60 minutes Lp: -0.2 - +0.5V (vs. SCE) at a scan rate of 0.1mVs-1 |
0.142 | 0.01191 | [64] | ||
SLM Fe35Mn | Scaffold | 62 | Electrochemical test | OCP: measured for 150 minutes EIS: amplitude of 10mV with scanning frequency between 100 kHz and 10 mHz Lp: ±0.25 V (vs. SCE) at a scan rate of 0.166mVs-1 |
0.8 | [53] | ||
SLM Fe35Mn | Scaffold | 62 | Immersion test |
Samples immersed for 28 days in Hank’s balanced salt solution with a pH of 7.4 |
0.42 ± 0.03 | [53] |
Material | Cell assay |
Cell line | Duration | Results | Ref. |
---|---|---|---|---|---|
Fe | Indirect | MG-63 | 3 days | good cytocompatibility, with cells normally grew on the scaffolds | [55] |
Fe25Mn | Indirect | MG-63 | 3 days | good cytocompatibility, with cells normally grew on the scaffolds | [55] |
Fe30Mn | Indirect | MC3T3-E1 | 7 days | RGR grade 0. The extract is not cytotoxic. | [64] |
Fe30Mn | Direct | MC3T3-E1 | 7 days | Seven days co-culture results in many live cells and only a few dead cells | [64] |
Fe35Mn | Indirect | MC3T3-E1 | 3 days | The scaffold displayed biocompatibility, high viability towards mammalian cells and filopodia on the scaffold indicated that the alloy is suitable for osteoblast adhesion | [53] |
Fe | Indirect | MG-63 | 3 days | MG-63 viability in extended, long-term extracts (72 h) of iron specimens dropped to below 50%. | [63] |
Fe | Direct | MG-63 | 1 day | revealed substantial and almost instant cytotoxicity | [63] |
Material | Shape | Animal | Implantation place | Duration | Results | Reference |
---|---|---|---|---|---|---|
Fe30Mn | Scaffold | Rabbit | lateral femoral condyle | 48 weeks | biocompatibility and osseointegration performances in the repair of load-bearing bone defects | [64] |
Fe35Mn | Scaffold | Rat | Cranium | 4 weeks | the implant integrated with the original bone, and even stimulated bone formation | [53] |
Material | Ev (J/mm3) | Yield Strength (MPa) | UTS | Elongation | Ref |
---|---|---|---|---|---|
Zn | 66.7 J/mm3 | 134 | 10 % | [80] | |
Zn2WE43 | 298.5 | 1.8 % | |||
Zn5WE43 | 335.4 | 1 % | |||
Zn8WE43 | 154.1 | 0.9 % | |||
Zn | 125 J/mm3 | 43.2 | 61.3 | 1.7 % | [83] |
Zn1Mg | 74 | 126 | 3.6 % | ||
Zn2Mg | 117 | 162 | 4.1 % | ||
Zn3Mg | 152 | 222 | 7.2 % | ||
Zn4Mg | 132 | 166 | 3.1 % | ||
Zn2Al | 76.19 J/mm3 | 120 | 170 | 9 % | [81] |
95.24 J/mm3 | 135 | 185 | 10 % | ||
114.28 J/mm3 | 140 | 190 | 12 % | ||
133.33 J/mm3 | 138 | 188 | 11 % | ||
Zn | 55.55 J/mm3 | 79.9 | 103.6 | 5.10% | [82] |
Zn1Ce | 140 | 210 | 6% | ||
Zn2Ce | 180.6 | 247.4 | 7.5% | ||
Zn3Ce | 182 | 230 | 6.8% | ||
Zn (Vertical) | 127 J/mm3 (300 mm/s) | 94 MPa | 119 MPa | 2,6% | [87] |
76,19 J/mm3 (500 mm/s) |
108 MPa | 130 MPa | 8% | ||
54.42 J/mm3 (700 mm/s) | 110.3 MPa | 132 MPa | 7% | ||
Zn (Horizontal) | 127 J/mm3 (300 mm/s) | 72 MPa | 90 MPa | 2,5% | |
54.42 J/mm3 (700 mm/s) | 75 MPa | 92.3 MPa | 5% | ||
Zn (Vertical) | 39 J/mm3 | 78 MPa | 100 MPa | 10% | [86] |
Zn (Horizontal) | 55 MPa | 79 MPa | 12% |
Material | Ev (J/mm3) | Structural porosity / pore size | Geometry | Ultimate Compressive strength (MPa) | Yield strength (MPa) | Elastic Modulus (GPa) |
Ref. |
---|---|---|---|---|---|---|---|
Zn | 39 J/mm3 | 73%- / 700 μm | Diamond | 4 | 0.4 | [60] | |
69% /Graded pore size 600 – 800 μm | Diamond | 6 | 0.5 | ||||
62% / 600 μm | Diamond | 11 | 0.8 | ||||
Zn | 39 J/mm3 | 20 – 40% | Diamond | 7 – 15 MPa* | [86] | ||
22 – 40% | Dodecahedron | 8 – 25 MPa* | |||||
25 – 45% | FCC | 10- 50 MPa* | |||||
22 – 35% | Kagome | 15 – 50 MPa* | |||||
30 – 50% | Octet Truss | 9 – 30 MPa* | |||||
Zn | 66.7 J/mm3 | 45% / 600 μm | Diamond | 23 | 13 | 0.95 | [80] |
Zn2WE43 | 60 | 51 | 1.91 | ||||
Zn5WE43 | 73 | 66 | 2.48 | ||||
Zn8WE43 | 51 | 51 | 2.54 | ||||
Zn | 100 J/mm3 | 50 % | Diamond | [84] | |||
Zn1Mg | 40 MPa | 1.2 | |||||
Zn2Mg | 35 MPa | 1.3 | |||||
Zn5Mg | 24 MPa | 1 | |||||
Zn0.7Li | 35.7 J/mm3 | 80% / 820 μm | Gyroid | 18.2 MPa | 0.298 | [85] |
Material | Part | Energy density (J/mm3) | Corrosion test | Conditions | CR (mm/year) | icorr (μA/cm2) | Ref. |
---|---|---|---|---|---|---|---|
Zn | Dense | 125 | Electrochemical | Samples soaked in SBF at 37ºC to obtain an OCP and polarization curves were recorded. | 0.14* | 9.24 ± 1.21 | [83] |
Zn1Mg | 0.09* | 5.86 ± 1.42 | |||||
Zn2Mg | 0.07* | 4.63 ± 0.95 | |||||
Zn3Mg | 0.05* | 3.62 ± 0.76 | |||||
Zn4Mg | 0.06* | 3.71 ± 0.87 | |||||
Zn | Dense | 125 | Immersion test | Samples immersed in SBF at 37ºC during 4 weeks | 0.18 ± 0.03 | [83] | |
Zn1Mg | 0.14 ± 0.01 | ||||||
Zn2Mg | 0.13 ± 0.03 | ||||||
Zn3Mg | 0.10 ± 0.02 | ||||||
Zn4Mg | 0.11 ± 0.04 | ||||||
Zn | Dense | Electrochemical | OCP: measured for 90 minutes (SBF). Scanning rate 1 mV/s | 0.12 | 7.76 | [88] | |
Zn2Ag | 0.08 | 5.01 | |||||
Zn4Ag | 0.02 | 1.47 | |||||
Zn6Ag | 0.15 | 9.56 | |||||
Zn8Ag | 0.21 | 13.94 | |||||
Zn | Dense | Immersion test | Samples immersed in SBF at 37ºC during 21 days | 0.081 | [88] | ||
Zn2Ag | 0.086 | ||||||
Zn4Ag | 0.107 | ||||||
Zn6Ag | 0.114 | ||||||
Zn8Ag | 0.133 | ||||||
Zn2Al | Dense | 95.24 | Electrochemical | Samples immersed in SBF at 37ºC. OCP ± 300 mV | 0.18 * | 11.75 | [81] |
114.28 | 0.12 * | 8 | |||||
133.33 | 0.10 * | 7.07 | |||||
Zn2Al | Dense | 95.24 | Immersion test | Samples immersed in SBF at 37 ºC during 14 days | 0.16 | [81] | |
114.28 | 0.14 | ||||||
133.33 | 0.12 | ||||||
Zn | Dense | Electrochemical | OCP: Measured for 50 min. Polarization curves obtained from -200 mV to 200 mV at 0.05 mV/s. EIS: 10^-2 - 10^6 Hz with a signal amplitude 10 mV | 0.13* | 9 | [82] | |
Zn1Ce | 0.12* | 8 | |||||
Zn2Ce | 0.11* | 7.2 | |||||
Zn3Ce | 0.10* | 6.9 | |||||
Zn | Dense | Immersion test | Samples immersed in SBF during 30 days | 0.034 | [82] | ||
Zn1Ce | 0.027 | ||||||
Zn2Ce | 0.025 | ||||||
Zn3Ce | 0.024 | ||||||
Zn0.7Li | Dense as built | Electrochemical test | EIS: frequency range 10^-2 - 10^5 Hz 10 mV | 1.5* | 101 ± 4.1 | [85] | |
Dense polished | 0.43* | 28.5 ± 1.6 | |||||
Scaffold (Porosity 80%) | 1.6* | 111.2 ± 12.2 | |||||
Zn0.7Li | Dense | Immersion test | Samples immersed in Hank`s solution at 37ºC during 28 days | 0.046 | [85] | ||
Scaffold (Porosity 80%) | Immersion test | Samples immersed in Hank`s solution at 37ºC during 28 days | 0.035 | ||||
Zn | Scaffold (Porosity 73%) | Immersion test | Samples immersed in revised simulated body fluid (r-SBF) during 28 days. Static and dynamic tests. Dynamic tests at a flow rate of 0.3 ml/min. | 0.17 (Dynamic), 0.07 (static) | [90] | ||
Scaffold (Porosity 69%) | 0.14 (Dynamic), 0.06 (static) | ||||||
Scaffold (Porosity 62%) | 0.13 (Dynamic), 0.07 (static) | ||||||
Zn | Scaffold (Porosity 62%) | Electrochemical test | r-SBF at 37ºC. Specimen was polarized from -0.2V to +0.5V potential versus OCP at 0.5 mV/s scan rate. | 0.67 ± 0.04 | 45 ± 2 | [91] | |
Immersion tests | r-SBF at 37ºC. For EIS, the tests were repeated at 1, 2, 7, 14, 21 and 28 days with 10 mV amplitude within a 100 kHz frequency range. | 0.13 mm/y (dynamic), 0.07 mm/y (static) | |||||
Zn | Scaffold (Porosity 50%) | Electrochemical tests | Sample immersed in Hank´s solution for 1.5h | [84] | |||
Zn1Mg | 0.20* | 13.5 ± 5.7 | |||||
Zn2Mg | 0.37* | 24.9 ± 10.6 | |||||
Zn5Mg | 0.60* | ± 11,3 |
Material | Cell assay | Cell line | Duration | Medium | Conditions | Results | Ref. |
---|---|---|---|---|---|---|---|
ZnxMg | Indirect | MG-63 cells | 6h, 1, 3 and 5 days | Dulbecco´s modified eagle medium DMEM + fetal bovine serum. | Dense samples. 100% and 50% extracts. Extracts were prepared at an area to volume ratio of 1.25 cm2/ml. | Good viability in 100% extract and better in 50% extracts. Cell viability increased with increasing exposure time. Mg content increases cell viability. Zn-3Mg best viability. | [83] |
ZnxCe | Indirect | Human osteosarcoma cells MG-63 | 1, 3 and 7 days | Dulbecco´s Modified Eagle Medium supplemented with 10% fetal bovine serum and antibiotics (100 units/ml penicillun and 100 units/ml streptomycin) | Dense samples. Extracts were prepared at a ratio of 1.25 cm2/ml. | Zn2Ce showed no obvious cell cytotoxicity. Cell viability of Zn2Ce (80.6%) was slightly lower than Zn (83.75%). | [82] |
Zn0.7Li | Direct | MC3T3-E1 pre-osteoblast | 2 h | Cell suspension was spread all over the surface of samples. | Bulk and porous samples. | Better cell adhesion and viability were found on porous samples in contrast with bulk samples. Cells were shrunk in a spherical shape and separated at the surface of bulk samples. While the cells exhibited a healthier morphology in porous samples. | [85] |
Zn2Al | Indirect | Human osteosarcoma cells MG-63 | 1, 4 and 7 days | Dulbecco´s modified eagle medium supplemented with 10% fetal bovine serum and antibiotics. | Dense samples. 100% and 50% extracts. Extracts were prepared at a ratio of 1.25 cm2/ml. | 100% extracts reduced the cell viability to 67.5%. Cell viability was higher than 80% for 50% extracts. With culture time the viability of cells increased significantly. | [81] |
Zn scaffolds |
Direct | Human osteoblast-like cells (MG-63) | 24 h | Dulbecco´s Modified Eagle Medium (DMEM) with 1g/L glucose, 10% fetal calf serum | Most cells were viable (> 70%) and a few exhibited evidence of a compromised cell membrane integrity | [90] | |
Indirect | 24, 48 and 72 h | Extract 0.2 g Zn/ml for 72 h | After 24h, cell viability in the extracts was higher than 95% for all porous specimens | ||||
Zn scaffolds | Direct | Human telomerase reverse transcriptase mesenchymal stem cells (hTERT-MSCs) | 14 days | high glucose Dulbecco´s Modified Eagle Medium supplemented with 10% fetal bovine serum and 1% PenStrep | Static seeding and dynamic seeding in a bioreactor | There was no indication of cell attachment and growth for the Zn scaffolds. | [86] |
Zn scaffolds | Indirect | MC3T3-E1 | 1, 3 and 5 days | α-minimal essential medium with- 10% fetal bovine serum | 100%, 50% and 10% extracts | Viability in 100% extract medium was below 75% after 1 day. Cell viability above 75% after 3 and 5 days. | [92] |
Zn scaffolds | Direct | Human osteoblasts like cells MG-63 | 24 h | Dulbecco´s Modified Eagle Medium (DMEM) with 1g/L glucose, 10% fetal calf serum | Most of the cells were viable, and results were similar to Ti6Al4V | [91] | |
Indirect | 24, 48 and 72 h | Extract 0.2 g Zn/ml for 72 h | Cell viability decreased from 95% at 24, 48 h to 85% at 72 h |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 MDPI (Basel, Switzerland) unless otherwise stated